The DOI matches its Crossref record.
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
Abstract
This is the first report describing up-regulation of telomerase activity in human normal cells. Telomerase, a ribonucleoprotein enzyme, has been thought to be involved in maintaining telomere length stability in germline and most cancer cells, but not in normal cells. However, in the present study, we demonstrate that telomerase activity is detectable at low levels in normal human T and B cells, increases by in vitro mitogenic stimulation, increases in hematopoietic progenitor cells upon their proliferation and differentiation, and decreases with aging. Understanding the regulation of telomerase activity in normal cells may provide important insights not only into the mechanisms of normal cellular senescence but also into the mechanisms of telomerase activity deregulation as part of cancer development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although we have to wait for the final report of the clinical trial, no significant adverse effects on normal tissues have been reported so far, even in hematopoietic cells, which may be highly susceptible to Telomelysin due to the presence of telomerase-positive stem cells. (35)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [35]
In the citing paper
“We should consider the fact that some normal cells, including some tissue stem cells, express relatively high levels of telomerase, (35,36,117) raising questions regarding the safety of Telomelysin.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [35]
Citations
Cited by
Sorted by citations
Items 601–700 of 859
de Abechuco, E. L., Bilbao, E., Soto, M., & Díez, G. (2014) · Gene · doi:10.1016/j.gene.2014.03.006 · Cited by 12
Telomerase regulation and the intimate relationship with aging
Morgan, G. (2013) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s28603 · Cited by 11
“This may explain the need for relatively high telomerase activity to maintain telomere length homeostasis in this cell compartment during an immune response.(39,41) Thus, age-related declines in telomerase activity may compromise stem cell-mediated tissue repair, germ cell viability, and immune cell function in humans.”
Polychronopoulou, S., & Koutroumba, P. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200406000-00003 · Cited by 13
Jacob, T., Hingorani, A., & Ascher, E. (2009) · Angiology · doi:10.1177/0003319709332956 · Cited by 12
“Telomerase activity has been reported to be elevated in some highly proliferative somatic cells.(13,14) We previously demonstrated that mitogenic stimuli like cotinine could activate telomerase in human VSMCs.”
BackgroundGranulomatous Disease Associated with Bartonella Infection in 2 Dogs
Pappalardo, B. L., Brown, T. T., Gookin, J. L., Morrill, C. L., & Breitschwerdt, E. B. (2000) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2000)014 · Cited by 84
Panarese, S., Brunetti, B., & Sarli, G. (2006) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063870601800407 · Cited by 12
Age related decrease of NOR activity in bone marrow metaphase chromosomes from healthy individuals.
Pedrazzini, E., Nn, M., & Slavutsky, I. R. (1998) · Molecular Pathology · doi:10.1136/mp.51.1.39 · Cited by 12
Marcon, F., Siniscalchi, E., Andreoli, C., Allione, A., Fiorito, G., Medda, E., Guarrera, S., Matullo, G., & Crebelli, R. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22127 · Cited by 12
“In this framework, the mitogen stimulation applied in this work was intended to switch on TA in circulating lymphocytes as expressed prior their differentiation [Hiyama et al., 1995b; Yamada et al., 1996].”
BackgroundMethodTelomerase Activity in Hodgkin's Disease
Brousset, P., Chaouche, N., Saati, T. A., et al. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809050942 · Cited by 12
Telomeres, X‐Inactivation Ratios, and Hematopoietic Stem Cell Transplantation in Humans: A Review
Thornley, I., & Freedman, M. H. (2002) · Stem Cells · doi:10.1634/stemcells.20-3-198 · Cited by 12
“Telomerase is variably present in hematopoietic progenitors and in peripheral blood monocytes and lymphocytes [ 40 ], but in these cells, its presence does not appear to completely attenuate telomeric shortening [35, 41-43].”
BackgroundMinamiguchi, H., Yahata, N., Kimura, T., Fujiki, H., Harada, S., Wang, J., Okuda, K., Kaneko, H., Hodohara, K., Banba, T., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02148.x · Cited by 12
“E-mail: sonoda@basic.kpu-m.ac.jp It was recently reported that primitive human haematopoietic stem/progenitor cells exhibit a low level of telomerase activity (Hiyama et al, 1995; Chiu et al, 1996; Morrison et al, 1996).”
BackgroundTelomerase is not activated in human hyperplastic and adenomatous parathyroid tissue
Velin, Å. K., Herder, A., Johansson, K., et al. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450161 · Cited by 12
“Several investigators have detected telomerase activity in different malignant tissues (2‐4), but not in benign or normal tissue, except for haematopoietic stem cells (14), basal cells of the epidermis (15), intestinal crypt cells (16) and activated lymphocytes ( 14 ), and telomerase expression is now widely accepted…”
BackgroundBoštík, P., Brice, G. T., Greenberg, K. P., Mayne, A. E., Villinger, F., Lewis, M. G., & Ansari, A. A. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200006010-00001 · Cited by 13
Mitochondria and telomeres: hand in glove
Vaurs, M., Dolu, E. B., & Decottignies, A. (2023) · Biogerontology · doi:10.1007/s10522-023-10074-7 · Cited by 11
“Nevertheless, germline cells and, to a lower extent, some proliferative cells like T or B cells still express TERT (Kim et al. 1994; Hiyama et al. 1995).”
Strategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
“Adult stem cells from the gut, skin and the hematopoietic system are typical tissues of high-turnover and telomerase activity is detectable (Hiyama et al. 1995; Chiu et al. 1996; Flores et al. 2008).”
BackgroundHaruta, Y., Hiyama, K., Ishioka, S., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0837 · Cited by 11
Self-citationOhshima, K., Sugihara, M., Haraoka, S., Suzumiya, J., Kanda, M., Kawasaki, C., Shimazaki, K., & Kikuchi, M. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057992 · Cited by 11
Molecular-targeted therapy for cancer
Dong, B., & Zhu, Y. (2010) · 癌症:英文版 · doi:10.5732/cjc.009.10313 · Cited by 11
Takagi, S., Kinouchi, Y., Chida, M., Hiwatashi, N., Noguchi, M., Takahashi, S., & Shimosegawa, T. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1026107429546 · Cited by 11
“Hiyama et al and Igarashi et al have demonstrated induction of telomerase activity in B lymphocytes after a subset of stimuli such as mitogens, anti-IgM antibodies, and anti-CD40 monoclonal antibody (11, 12).”
BackgroundLiu, X., Lin, J., Wang, L., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08377.x · Cited by 11
Re, M. C., Monari, P., Gibellini, D., Ciancianaini, P., Dall'Aglio, P. P., Vignoli, M., Furlini, G., Ramazzotti, E., Bertazzoni, U., & Casoli, C. (2000) · Stem Cells and Development · doi:10.1089/152581600419143 · Cited by 11
“However, telomerase is up-regulated when cells enter the cell cycle (4–6), and so its expression may also correlate with the proliferative capacity of hematopoietic progenitor cells.”
Banerjee, P. P., Banerjee, S., Zirkin, B. R., & Brown, T. R. (1998) · Endocrinology · doi:10.1210/endo.139.3.5839 · Cited by 12
Rengelshausen, J., Randerath, I. E., Schettgen, T., Esser, A., Kaifie, A., Lang, J., Kraus, T., & Ziegler, P. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03578-1 · Cited by 14
Rothacker, J., Ramsay, R. G., Ciznadija, D., Gras, E., Neylon, C. B., Elwood, N. J., Bouchier‐Hayes, D. M., Gibbs, P., Rosenthal, M. A., & Nice, E. C. (2007) · Electrophoresis · doi:10.1002/elps.200600829 · Cited by 10
Safont, M. J., Gil-Raga, M., Sirera, R., Lewintre, E. J., Sanmartín, E., Gallach, S., Caballero, C., del Pozo, N., Palomares, E., & Camps, C. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0673-2 · Cited by 11
“Also telomerase expression has been described in tissues with high proliferation levels, such as haematopoietic cells [ 12 ], basal cells of the epidermis [13] and cells from the intestinal crypt [14].”
BackgroundPossible molecular mechanisms underlying the development of atherosclerosis in cancer survivors
Banerjee, P., Rosales, J. E., Chau, K. M., Nguyen, M. T., Kotla, S., Lin, S. H., Deswal, A. M., Dantzer, R., Olmsted‐Davis, E. A., Nguyen, H., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1186679 · Cited by 10
Intrinsic control of stem cell fate
Lansdorp, P. M. (1997) · Stem Cells · doi:10.1002/stem.5530150830 · Cited by 9
Telomerase activity and cell proliferation index in cholesteatoma
Lee, S. H., Jang, Y. H., Tae, K., et al. (2005) · Acta Oto-Laryngologica · doi:10.1080/00016480410024479 · Cited by 10
“As a result, telomerase activity is considered to be a biological index of cell proliferation rather than malignancy [3,4].”
BackgroundTelomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues
Tominaga, T., Kashimura, H., Suzuki, K., Nakahara, A., Tanaka, N., Noguchi, M., Itabashi, M., & Ohkawa, J. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200061 · Cited by 10
The telomerase activities in several organs and strains of rats with ageing
Suzui, N., Yoshimi, N., Kawabata, K., et al. (1999) · Laboratory Animals · doi:10.1258/002367799780578408 · Cited by 10
Hara, T., Mizuguchi, M., Fujii, M., & Nakamura, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610386 · Cited by 10
Telomere-related components are coordinately synthesized during human T-lymphocyte activation
Kosciolek, B. A., & Rowley, P. T. (1999) · Leukemia Research · doi:10.1016/s0145-2126(99)00134-4 · Cited by 10
Telomeres, Telomerase, and Lupus: The Long and Short of It
Rus, V., & Via, C. S. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5034 · Cited by 9
Iki, K., Tsujiuchi, T., Majima, T., Sakitani, H., Tsutsumi, M., Takahama, M., Yoshimoto, M., Nakae, D., Tsunoda, T., & Konishi, Y. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00148-7 · Cited by 10
Telomerase activity might persist in the human thymus throughout life
Brousset, P., Saati, T. A., Zenou, R. C., & Delsol, G. (1998) · Molecular Pathology · doi:10.1136/mp.51.3.170 · Cited by 9
Regulation of apoptosis and replicative senescence in CD8+ T cell following acute viral infection
Plunkett, F. J., Soares, M. V. D., Salmon, M., & Akbar, A. N. (2000) · APOPTOSIS · doi:10.1023/a:1009672331030 · Cited by 10
Telomerase: is it the future diagnostic and prognostic tool in human cancer?
Mabruk, M. J. E. M. F., & O’Flatharta, C. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.6.907 · Cited by 10
Murakami, Y., Yokoyama, T., Hiyama, E., et al. (2002) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:31:1-3:117 · Cited by 10
“A cell extract of 1 µL (1000 cells) was used for TRAP assay to avoid the false-positive result by contaminating lymphocytes, which have weak telomerase activity ( 15 ).”
BackgroundMethodInfluentialSelf-citationTelomerase dynamics in stem cells: Unraveling the molecular nexus of cellular aging and regeneration
Jiang, Y., Zhou, Y., Wang, Y., Li, Z., Ashraf, G. M., & Guo, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102853 · Cited by 12
Effects on Glial Cell Glycolysis in Schizophrenia: An Advanced Aging Phenotype?
Zuccoli, G. S., Guest, P. C., & Martins‐de‐Souza, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_2 · Cited by 9
Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens
Fujita, H., Ohuchida, K., Mizumoto, K., Egami, T., Miyasaka, Y., Yamaguchi, H., Yu, J., Cui, L., Onimaru, M., Takahata, S., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00930.x · Cited by 9
Genes associated with telomerase activity levels in esophageal carcinoma cell lines
Bergqvist, M., Brattström, D., Brodin, D., et al. (2005) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2006.00532.x · Cited by 9
Kurosaka, D., Yasuda, J., Ikeshima‐Kataoka, H., et al. (2007) · Modern Rheumatology · doi:10.1007/s10165-007-0583-x · Cited by 9
The Cytotoxic Effects of Single-Stranded Telomere Mimics on OMA-BL1 Cells
Page, T. J., Mata, J. E., Bridge, J. A., Siebler, J., Neff, J. R., & Iversen, P. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4613 · Cited by 10
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies
Li, C. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i17.2468 · Cited by 9
Hotchkiss, G., Pehrson, P.-O., Larsson, S., Ährlund‐Richter, L., & Britton, S. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199912150-00004 · Cited by 11
hTR repressor-related gene on human chromosome 10p15.1
Miura, N., Onuki, N., Rathi, A., Virmani, A. K., Nakamoto, S., Kishimoto, Y., Murawaki, Y., Kawasaki, H., Hasegawa, J., Oshimura, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2121 · Cited by 9
“…in vitro and in primary tumour tissues, most fetal tissues, and normal adult male reproductive cells and represents an important difference between normal somatic cells and cancer cells (Kim et al, 1994; Hiyama et al, 1995; Rhyu, 1995; Wright et al, 1996; Shay and Bacchetti, 1997; Sedivy, 1998).”
BackgroundKUBOTA, M., Yamana, H., Sueyoshi, S., Fujita, H., & Shirouzu, K. (2002) · International Journal of Clinical Oncology · doi:10.1007/s101470200003 · Cited by 9
“Hiyama et al.(20) demonstrated that low telomerase activity was detected in healthy human PBMC and that the activity was increased by in-vitro mitogenic stimulation.”
BackgroundTelomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
Dratwa, M., Łacina, P., Butrym, A. K., Porzuczek, D., Mazur, G. J., & Bogunia‐Kubik, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-43141-7 · Cited by 8
Nelson, N. E., Feurstein, S. K., Niaz, A., Truong, J. Q., Holien, J. K., Lucas, S. E. M., Fairfax, K. A., Dickinson, J. L., & Bryan, T. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.11.021 · Cited by 8
Telomere length and vitamin B12
Guruvaiah, P., Sivaprasad, M., & Reddy, G. B. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2022.01.014 · Cited by 8
Assessment and Quantification of Telomerase Enzyme Activity
Maritz, M. F., Richards, L. A., & MacKenzie, K. L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_14 · Cited by 8
Handa, H., Matsushima, T., Nishimoto, N., Inoue, M., Saitoh, T., Yokohama, A., Tsukamoto, N., Mitsui, T., Nakahashi, H., Toyama, K., et al. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.06.010 · Cited by 8
“The lack of hTERT expression in neutrophils correlates with previous findings which have generally shown that telomerase activity is not present in these cells [5,6].”
BackgroundInfluentialMitsuishi, T., Iwabu, Y., Tokunaga, K., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-118 · Cited by 8
“demonstrated that leukocytes constitutively express low levels of TA [31].”
BackgroundTelomerase activation--one step on the road to carcinoma of the gall bladder.
Shukla, V. K., Chauhan, V. S., & Kumar, M. (2006) · PubMed · Cited by 8
Spangler, E. A., Rogers, K. S., Thomas, J. S., Pustejovsky, D., Boyd, S. L., & Shippen, D. E. (2000) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2000.tb02228.x · Cited by 14
Pradhan, P., & Nguyen, M. L. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0773-7 · Cited by 8
Yamaguchi, K., Chijiiwa, K., Torata, N., Kinoshita, M., & Tanaka, M. (2002) · HPB · doi:10.1080/136518202760378434 · Cited by 8
Telomerase Activity in Giant Condyloma acuminatum
Ikeda, R., Kobayashi, Y., Shiroma, K., et al. (2000) · Urologia Internationalis · doi:10.1159/000064883 · Cited by 8
Pandita, T. K., Benvenuto, J. A., Shay, J. W., PANDITA, R. K., Rakovitch, E., Geard, C. R., Antman, K. H., & Newman, R. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00766-6 · Cited by 8
Self-citationCD4 T cell signaling in the natural siv host implications for disease pathogenesis
Boštík, P. (2003) · Frontiers in bioscience · doi:10.2741/1147 · Cited by 8
“The quantitative level of telomerase activity has been shown to serve as a marker of cell proliferation and telomerase activity in lymphocytes increases with immune activation (10-12).”
BackgroundMeasurement of telomerase activity in bovine leukaemia virus infected cows
Suzuki, K., Shuto, S., Miura, Y., et al. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.08.016 · Cited by 8
Real-time telomerase activity measurements for detection of cancer
Jakupciak, J. P. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.5.745 · Cited by 8
Proctor, A., Brownhill, S. C., & Burchill, S. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.011 · Cited by 9
Impact of culture conditions on the proliferative lifespan of human T cells in vitro
Röth, A., Schneider, L., Himmelreich, H., Baerlocher, G. M., & Dührsen, U. (2006) · Cytotherapy · doi:10.1080/14653240601113197 · Cited by 8
Telomerase: Putting an End to DNA
Rowley, P. T. (1998) · Cancer Investigation · doi:10.3109/07357909809050032 · Cited by 8
Telomerase Activity Levels for Evaluating the Surgical Margin in Breast-Conserving Surgery
Hara, Y., Iwase, H., Toyama, T., Yamashita, H., Omoto, Y., Fujii, Y., & Kobayashi, S. (2001) · Surgery Today · doi:10.1007/s005950170147 · Cited by 8
Three molecular determinants of malignant conversion and their potential as therapeutic targets
Dome, J. S., & Look, A. T. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00013 · Cited by 8
Lilleby, W. A., Seierstad, T., Inderberg, E. M., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34448 · Cited by 7
Kamada, M., Kumazaki, T., Matsuo, T., et al. (2012) · Cell Biology International · doi:10.1042/cbi20110460 · Cited by 7
“Human tissue stem cells, such as haematopoietic stem cells, have some telomerase activity (Broccoli et al., 1995; Hiyama et al., 1995) and have been used for transplantation to patients (Cutler and Antin, 2001; Nivison-Smith et al.”
BackgroundMethodTelomeres and Estrogens: The Unholy Nexus in Pathogenesis of Atherosclerosis
Sameer (2014) · Cardiology Research · doi:10.14740/cr335e · Cited by 7
“activated lymphocytes and certain types of stem cells [18-20].”
BackgroundContributions of Telomere Biology to Human Age-Related Disease
Yang, T.-L., Song, S., & Johnson, F. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00007-1 · Cited by 9
Melicher, D., Illés, A., Pállinger, É., Kovács, Á. F., Littvay, L., Tárnoki, Á. D., Tárnoki, D. L., Bikov, A., Molnár, M. J., Buzás, E. I., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2738-z · Cited by 8
Kurosaka, D., Yasuda, J., Ikeshima‐Kataoka, H., et al. (2007) · Modern Rheumatology · doi:10.3109/s10165-007-0583-x · Cited by 7
“Telomerase activity is known as an indicator of increased lymphocyte division.(4) We reported that peripheral lymphocytes from SLE patients had a high telomerase activity, suggesting the active division of peripheral blood lymphocytes from SLE patients.”
BackgroundA high-throughput assay for a human telomerase protein–human telomerase RNA interaction
Keppler, B. R., & Jarstfer, M. B. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.03.027 · Cited by 7
Lund, J. R., Paoloni, M., Kurzman, I. D., Padilla, M. L., & Argyle, D. J. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.09.015 · Cited by 7
Telomerase activity detected in eyed embryos of rainbow trout Oncorhynchus mykiss
YODA, M., Takahashi, K., & Mori, K. (2002) · Fisheries Science · doi:10.1046/j.1444-2906.2002.00398.x · Cited by 7
Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures
Stöppler, H., Stoppler, M. C., Kisiela, M., Holzbach, A., Moll, I., Houdek, P., & Moll, R. (2001) · Archives of Dermatological Research · doi:10.1007/s004030100241 · Cited by 7
Sakitani, H., Tsujiuchi, T., Kobitsu, K., Kido, A., Iki, K., Takahama, M., Nakamura, M., Sakaki, T., Nakae, D., Konishi, Y., et al. (1998) · Cancer Letters · doi:10.1016/s0304-3835(97)00549-1 · Cited by 7
“Normal tissues have no telomerase activity, except for germ cells, lymphocytes, hematopoietic progenitor cells and epidermal keratinocytes [15–19].”
BackgroundTelomeres and Cell Division Potential
Perrem, K., & Reddel, R. R. (1999) · Progress in molecular and subcellular biology · doi:10.1007/978-3-662-06227-2_8 · Cited by 6
Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan, K., Lertworawiwat, A., Tscheikuna, J., & Wamanuttajinda, V. (2006) · PubMed · Cited by 6
Yang, C., Lin, M., Huang, C.-C., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00072-7 · Cited by 6
Regulation of Telomerase Activity
Nalobin, D. S., Galiakberova, A. A., Alipkina, S. I., & Glukhov, A. I. (2018) · Biology Bulletin Reviews · doi:10.1134/s2079086418020068 · Cited by 6
Mattson, M. P., Zhang, P., & Cheng, A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-133-8_15 · Cited by 6
Pawelec, G. (2003) · Springer eBooks · doi:10.1007/978-94-017-0669-8_6 · Cited by 6
Feist, H., Zeidler, R., Skrebsky, T., Schmatloch, S., & Kreipe, H. H. (1998) · Annals of Hematology · doi:10.1007/s002770050374 · Cited by 6
“Our results concerning telomerase activity in peripheral lymphocytes and inducibility of the enzyme are well in line with the recent publications on this issue [4, 6, 7, 11, 17, 33].”
BackgroundResultInhibition of telomerase in canine cancer cells following telomestatin treatment
Long, S., Argyle, D. J., Gault, E. A., et al. (2007) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2006.00118.x · Cited by 6
Telomeres, telomerase, and the cell cycle
Buchkovich, K. J. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_18 · Cited by 6
Kanamaru, T., Morita, Y., Itoh, T., Yamamoto, M., Kuroda, Y., & Hisatomi, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03277.x · Cited by 6
Russo, D. A., Petryk, A., & August, C. S. (1997) · Transplantation Proceedings · doi:10.1016/s0041-1345(97)00204-2 · Cited by 6
Brousset, P., Saati, T. A., Chaouche, N., et al. (1997) · Blood · doi:10.1182/blood.v89.1.26.26_26_31 · Cited by 6
Atypical glandular cells of undetermined significance
Soofer, S. B., & Sidawy, M. K. (2000) · Cancer · doi:10.1002/1097-0142(20000825)90:4 · Cited by 57
Self-citationBarsov, E. V. (2011) · Current Protocols in Immunology · doi:10.1002/0471142735.im0721bs95 · Cited by 5
“Circulating quiescent T cells do not express TERT; however, TERT activity is sharply elevated in activated human T cells (Hiyama et al., 1995; Weng et al., 1996, 1997a,b, 1998; Haruta et al., 1999) and may play a role in supporting the survival, proliferation, and expansion of antigen-responding T…”
BackgroundTargeting Telomerase in Hematologic Malignancy
Maritz, M. F., Napier, C. E., Wen, V. W., & MacKenzie, K. L. (2010) · Future Oncology · doi:10.2217/fon.10.42 · Cited by 5
“Telomeres & telomerase during normal hematopoiesis & in hematologic disorders Expression of telomerase during normal hematopoiesis Telomerase is expressed at very low or undetectable levels in most normal somatic cells, with the notable exception of stem and progenitor cells [26,52,53].”
BackgroundTelomerase activity and apoptosis genes as parameters of lymphocyte aging in Down syndrome patients
Abdel-Salam, E., Abdel-Meguid, I. E., & Korraa, S. (2013) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2013.01.001 · Cited by 5
“This mechanism is crucial for the suicide of activated T cells and macrophages [29].”
BackgroundMizuguchi, M., Hara, T., Yoshita‐Takahashi, M., Kohda, T., Tanaka, Y., & Nakamura, M. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100984 · Cited by 5
Aspirin inhibits human telomerase activation in unstable carotid plaques
Li, F., Guo, Y. M., JIANG, X., et al. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1082 · Cited by 5
“In general, telomerase is inhibited in inflammatory cells (21,22).”
BackgroundTelomerase and non-Telomerase Mechanisms of Telomere Maintenance
Morrish, T. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73734 · Cited by 6
Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer
Zhang, W., Veisaga, M. L., & Barbieri, M. A. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112318 · Cited by 5
Aras, G., Kanmaz, D., Urer, N., Purısa, S., Kadakal, F., Yentürk, E., & Tuncay, E. (2013) · PubMed · Cited by 5
Metadata
- Authors
- Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M.
- Affiliations
- Hiroshima University (JP)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-10
- Volume
- 155
- Issue
- 8
- Pages
- 3711-3715
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1516272650
- Cited by
- 853
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 10 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 13 · 2018: 11 · 2017: 8 · 2016: 13 · 2015: 15 · 2014: 17 · 2013: 20 · 2012: 17
- FWCI
- 38.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG07992, R01AG007992)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomerase, telomerase activity, lymphocytes, T cells, B cells, hematopoietic progenitor cells, mitogen stimulation, aging, cellular senescence, telomere length, carcinogenesis, normal cells
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Base Sequence, Bone Marrow Cells, Cell Separation, Child, Child, Preschool, Enzyme Activation, Hematopoietic Stem Cells, Humans, Infant, Infant, Newborn, Leukocytes, Mononuclear, Lymphocyte Activation, Lymphocytes, Male, Middle Aged, Molecular Sequence Data, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review